Studies from Shanxi Medical University Describe New Findings in Ovarian Cancer (Mir-30a-5p/chd1 Axis Enhances Cisplatin Sensitivity of Ovarian Cancer Cells Via Inactivating the Wnt/beta-catenin Pathway)

Press/Media

Period17 Nov 2022

Media coverage

1

Media coverage